DR. REDDY’S ANNOUNCES THE FIRST-TO-MARKET LAUNCH OF SUGAMMADEX INJECTION 200 MG/2 ML (100 MG/ML) AND 500 MG/5 ML (100 MG/ML) SINGLE-DOSE VIALS, A GENERIC EQUIVALENT OF BRIDION®, IN THE UNITED STATES